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Background: Plasma volume (PV) expansion drives systemic congestion in chronic heart failure (CHF) and is a plausible substrate for exercise 
limitation. Because no simply means of quantifying PV in CHF exists, we derived an index of relative PV status (PVS) and tested its relation to exercise 
performance in CHF patients (pts).
methods: We analysed data from 123 systolic CHF pts (age 66±13yrs, 70% male, 32% NYHA class≥ 3, PVO2 1438±703 mL/min, PVO2/kg 18±7 
mL/kg/min). PVS was calculated by subtracting a validated equation for ideal PV (c x weight) from one for current PV ([1-hematocrit] x [a + (b x 
weight)]) with the results expressed as a % of ideal PV.
results: Median PVS was - 9±13% with 15% of pts having PV expansion. Higher PVS correlated to lower absolute PVO2 (r = - 0.62, P<0.0001, Fig 
A), PVO2/kg (r = - 0.34, P>0.001), and oxygen uptake efficiency slopes (r = - 0.51, P<0.0001, Fig B). On simple regression, PVS, age, female gender, 
peak systolic BP, ischemic etiology, NYHA class, diuretic therapy, and β-blocker use related to PVO2. On multiple regression, only PVS (r= - 0.34), 
age (r= - 0.48), and peak systolic BP (r=0.17) independently predicted PVO2 (r2 = 0.66, P - 5% optimally forecasted severe exercise limitation as 
marked by a PVO2/kg ≤14 mL/kg/min (area under the curve 0.62, 95% CI 0.53-0.71, P=0.02).
conclusions: Plasma volume expansion identified using simple clinical indices relates to exercise intolerance in CHF and titrating therapies to PVS 
might improve functional capacity.
 
